3M Co. (NYSE:MMM) beat expectations for its 4th-quarter profits and affirmed its guidance for 2012, but Wall Street remained unmoved, with shares staying flat in this morning’s trading.
Getinge
Maquet restructures to meet shifting OR needs
Getinge Group subsidiary Maquet restructured the organization of its U.S. sales and services to meet the growing hybrid operating room market.
Hybrid OR’s contain both a traditional operating room and a cardiac catheterization lab, minimizing the need to move a sick patient from room to room for complex procedures.
The suites are designed to foster collaboration between cardiologists, cardiac surgeons, interventional radiologists and vascular surgeons and build a more efficient workflow.
J&J unit completes SterilMed acquisition | Acquisitions Roundup
Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery division finished its acquisition of Minnesota-based medical device reprocessor SterilMed Inc for an undisclosed amount.
SterilMed reprocesses medical devices and provides equipment repair and pre-owned equipment sales services. Johnson & Johnson said it plans to keep the SterilMed brand running as it integrates the business into the EES segment.
Baxter boosts forecast after strong Q3 | Earnings Roundup
Baxter International Inc. (NYSE:BAX) said it now expects to post earnings of at least $4.29 per share this year, after logging strong third-quarter results.
FDA warns Lasik docs to stay honest in advertising, Getinge pays $680 million for Atrium Medical, DJO’s executive VP resigns | MassDevice.com +3
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Getinge Group pays $680 million for Atrium Medical | Acquisitions Roundup
Sweden-based Getinge Group announced a definitive agreement to acquire soft tissue reinforcement technology developer Atrium Medical for $680 million.
Atrium will operate as an independent, self-contained unit of Getinge subsidiary Maquet Cardiovascular and will continue to be led by current Atrium president, Trevor Carlton, according to a press release.
Getinge Group and subsidiary Maquet Cardiovascular sign agreement to acquire Atrium Medical for $680 Million
— Atrium’s products strategically augment MAQUET Cardiovascular’s global business —
WAYNE, N.J., Oct. 3, 2011 /PRNewswire/ — GETINGE GROUP (STO:GETIB) and its subsidiary, MAQUET Cardiovascular, a global leading provider of cardiovascular technologies, announced today that it has signed a definitive agreement to acquire Atrium Medical Corporation for $680 million. Atrium is a leader in medical device technologies for interventional cardiology and radiology, chest trauma care and thoracic drainage, vascular surgery, and general surgery. Atrium will operate as an independent, self-contained business unit of MAQUET Cardiovascular and will be led by current Atrium president, Trevor Carlton.
Getinge’s Q2 sales, earnings slide | Earnings Roundup
Second-quarter sales and earnings may have slipped for Swedish medical device maker Getinge AB (STO:GETI B), but that hasn’t stopped it from issuing an ambitious plan to boost its profits.
Thoratec buys heart pump technology from Swedish firm
Thoratec Corp. (NSDQ:THOR) has struck a deal to acquire catheter-pump technology from a Swedish company for $8.5 million in cash.
The percutaneous heart pump first developed by Getinge AB (OMX:GIND-B) is driven by an external motor using a flexible drive shaft and has shown the ability to move over 4.5 liters per minute during laboratory tests. Executives at Pleasanton, Calif.-based Thoratec said the acquired technology will be used to further development on axial-flow pumps that would be placed into the heart through minimally invasive catheter procedures.